BeStock  
Markets › Compare › PACB vs CTKB

PACB vs CTKB

Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.

vsvs
PACB · Pacific Biosciences of California$1.63 ▼ 7.39%
CTKB · Cytek Biosciences$6.12 ▼ 3.16%

One year, rebased to 100

Each line starts at 100 so growth is directly comparable

406080100120Nov 24, '25May 26, '26Nov 20, '26
  • PACB -34.8%
  • CTKB +4.8%

Head to head

MetricPACBCTKB
Price$1.63$6.12
Change today▼ 7.39%▼ 3.16%
Market cap$510.07M$800.40M
Return, 3 months+27.3%+37.8%
Return, year to date-12.8%+21.2%
Return, 1 year-26.6%+4.1%
P/E (TTM)––
P/B-8.32.5
P/E percentile vs own 5y47th70th
Dividend yield––
Revenue growth (YoY, latest qtr)+5.5%+1.8%
Net profit growth (YoY)+0.4%-11.3%
Gross margin34.4%54.7%
Operating margin-100.1%-21.1%
Net margin-81.3%-39.1%
Return on equity–-23.2%
Analyst target vs. price+62.0%+18.5%
Analyst buy share40%100%
RSI (14)3557
30-day volatility107.0%58.9%
Max drawdown, 1 year-58.4%-42.9%
Trend readLeaning bearishStrong uptrend
Analyst consensusHoldBuy

Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.

What the numbers say

  • CTKB is the largest of the group by market value.
  • CTKB has returned the most over the past year.
  • PACB is growing revenue fastest.
  • CTKB keeps the most profit per dollar of sales.
  • CTKB has been the calmest stock over the last 30 days.

Go deeper

Scroll to Top